We’re changing
Diagnosis
so she can change the world
TODAY, 176 MILLION WOMEN SUFFER FROM ENDOMETRIOSIS, BUT YOU WOULD HARDLY KNOW IT.
That's because in many ways, to describe the disease is to describe the invisible. With the DotEndo test, we're uncloaking endometriosis and filling the diagnostic gap that is over a century old.
Clarity through science
Endometriosis is a complex, heterogeneous disease that may present inconsistently across patients. By measuring disease-specific biomarkers and applying advanced biostatistics, DotEndo provides the information you need to attribute her symptoms.
ACTIONABLE AND NON-INVASIVE
DotEndo is being developed to empower women to end their diagnostic odyssey through providing a non-invasive option for endometriosis testing. This is more than a risk profile; this is an answer.
Paradigm Shift
When did we accept that a woman can wait years for answers to her health? Did it begin when her physician mistook her chronic pain as “all in her head?” Was it when she paused at the thought of laparoscopy for diagnosis, not ready to face the physical, emotional, and financial burdens of surgery? At DotLab, we're ending the delay because an easy test means an early, actionable answer.